Transcatheter Heart Valve Replacement and Repair Market

The Transcatheter Heart Valve Replacement and Repair industry can be broken down into several segments, TAVR, TPVR and TMVR.
Valvular heart diseases are associated with the person?s advancing age, caused by the congenital defects or inefficiency of valves to function. Valve dysfunction results in restricting physical activities that leads to decline in quality of life and even death. Hence, due to these reasons many years have been spent on developing heart valve devices in order to repair and replace the damaged heart valves. Over the past few years innovation and recent technological advancements have resulted in manufacturing of transcatheter heart valve that are less risky and need minimally invasive surgical procedure. Increase in number of people with valvular heart disease and rise in demand for minimally invasive surgical procedure will augment the growth of transcatheter heart valve replacement industry in the near future.
Transcatheter Heart Valve Replacement and Repair Market contains market size and forecasts of Transcatheter Heart Valve Replacement and Repair in Global, including the following market information:
Global Transcatheter Heart Valve Replacement and Repair Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Transcatheter Heart Valve Replacement and Repair market was valued at 6136.5 million in 2021 and is projected to reach US$ 15880 million by 2028, at a CAGR of 14.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
TAVR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transcatheter Heart Valve Replacement and Repair include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Venus Medtech, Meril Life Sciences and Braile Biomedica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transcatheter Heart Valve Replacement and Repair companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transcatheter Heart Valve Replacement and Repair Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transcatheter Heart Valve Replacement and Repair Market Segment Percentages, by Type, 2021 (%)
TAVR
TPVR
TMVR
Global Transcatheter Heart Valve Replacement and Repair Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transcatheter Heart Valve Replacement and Repair Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Global Transcatheter Heart Valve Replacement and Repair Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transcatheter Heart Valve Replacement and Repair Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transcatheter Heart Valve Replacement and Repair revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Transcatheter Heart Valve Replacement and Repair revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica